3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Lymphoma
15
Neutropenia
9
Lymphoma, Large B-Cell, Diffuse
7
Leukemia
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Hodgkin Disease
4
Chemotherapy-induced Neutropenia
4
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Breast Neoplasms, Male
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma of Lung
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Interventions
Dexamethasone
9
Calcium Dobesilate
7
Bortezomib
5
Melphalan
4
Cyclophosphamide
3
ixazomib
2
Thalidomide
2
Doxycycline
2
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
birtamimab
1
auricularum
1
Tacrolimus
1
Lenalidomide
1
Etoposide
1
Doxorubicin
1
Cisplatin
1
Bendamustine Hydrochloride
1
Antilymphocyte Serum
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Amyloidosis
×
pegfilgrastim
×
Clear all
No trials found.